Reply to: Why Amyloid Is Still a Target for Alzheimer's Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reply to: Why Amyloid Is Still a Target for Alzheimer's Disease

Published:2019-03-09 Issue:4 Volume:67 Page:850-850
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J Am Geriatr Soc

Author:

Zhao Hai-Lu¹,Huang Yan-Mei¹

Affiliation:

1. Department of Immunology, Guangxi Area of Excellence; Guilin Medical University; Guilin China

Funder

Innovation Project of Guangxi Graduate Education

National Natural Science Foundation of China

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgs.15827/fullpdf

Reference5 articles.

1. Major clinical trials failed the amyloid hypothesis of Alzheimer's disease;Huang;J Am Geriatr Soc,2019

2. Why amyloid is still a target for AD clinical trials;McDade;J Am Geriatr Soc,2019

3. Amyloid-beta vaccination: testing the amyloid hypothesis? heads we win, tails you lose!;Lee;Am J Pathol,2006

4. Amyloid-beta junkies;Perry;Lancet,2000

5. Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders;Vellas;Curr Alzheimer Res,2009

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses;Frontiers in Immunology;2020-01-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP